Global Biomarkers Market Outlook & Forecast 2022-2027: Increase In Number of Pipeline Biomarkers & Rising Adoption of Biomarkers In Disease…

DUBLIN--(BUSINESS WIRE)--The "Biomarkers Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global biomarkers market is expected to grow at a CAGR of 11.44%.

In-depth Analysis and Data-driven Insights on the Vendor Landscape, Competitive Analysis, and Critical Market Strategies are Included in this Global Biomarkers Market Report.

Biomarkers are increasingly useful tools to predict prognosis and response to therapy in cancer patients. Furthermore, it allows to improve understanding of mechanisms of action and resistance to treatment.

GLOBAL BIOMARKERS MARKET SEGMENTATION

Oncology dominated the indication segment because biomarkers are being largely used for cancer research and diagnostics due to its high prevalence worldwide. Biomarkers in the field of oncology has revolutionized the diagnostics and treatment pathways.

Diagnostics dominated the application segment. However, the application of biomarkers in drug discovery & development is expected to grow significantly during the forecast period because biomarkers studies is expected to become an integral part of the drug development process with the aim of developing more effective drugs at a lower cost

Diagnostic biomarker dominated the type of segment as diagnostic biomarker studies have entered a new era where it holds promise for early diagnosis and effective treatment of many diseases.

GEOGRAPHICAL ANALYSIS

North America dominated the geography because biomarkers have been in use highly for diagnostic purposes, drug discovery & development, and precision medicine. The increase in R&D expenditures and fundings for biomarker-driven drug discovery & development and precision medicine is one of the major driving factors in all the regions.

APAC is anticipated to exhibit the highest CAGR of 13.96% during the forecast period. Increasing developments and incorporation of advanced technologies to enhance the biomarker-based testing and increasing demand for biomarkers in drug development and personalized medicine are one of the primary factors in the region.

KEY HIGHLIGHTS

Increased Adoption of Biomarkers in Personalized Medicine is driving the global biomarkers market growth. As many healthcare settings have gained interest in personalized/precision medicine, many vendors have increased the studies focusing on identifying biomarkers to provide healthcare system solutions to them.

Increasing focus on digital biomarkers will also drive the global Currently, several digital biomarkers are being tested for feasibility and reliability in Parkinson's and Alzheimer's disease and clinical outcome assessments.

Increasing discovery of epigenetic biomarkers for oncology is also driving the biomarker technologies market. There are more emerging companies increasing their research & development focus on discovering more epigenetics to diagnose various types of cancers.

Technological Advancements in Biomarker Discovery are also positively impacting the biomarkers diagnostics industry. For instance, a recent development in portable biosensors allows rapid, accurate, and on-site detection of biomarkers, which helps prevent disease spread by controlling sources.

VENDOR ANALYSIS

Multiple companies partnering and investing in biomarkers research and development will help the companies to innovate new drugs and reduce the economic burden.

Key Vendors

Other Prominent Vendors

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.1.1 Inclusions

4.1.2 Exclusions

4.1.3 Market Estimation Caveats

4.2 Base Year

4.3 Scope of the Study

4.4 Market Segments

4.4.1 Market Segmentation by Indication

4.4.2 Market Segmentation by Application

4.4.3 Market Segmentation by Type

4.4.5 Market Segmentation by Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at a Glance

7 Introduction

7.1 Overview

8 Market Opportunities & Trends

8.1 Increased Adoption of Biomarkers in Personalized Medicine

8.2 Increasing Focus on Digital Biomarkers

8.3 Increased Discovery of Epigenetic Biomarkers in Oncology

9 Market Growth Enablers

9.1 Increase in the Number of Pipeline Biomarkers

9.2 Rising Adoption of Biomarkers in Disease Diagnostics

9.3 Technological Advancements in Biomarker Discovery

10 Market Restraints

10.1 High Cost and Time-Consuming Development

10.2 High Number of False Discoveries

10.3 Strict Regulations and Ethics for Biomarker Validation & Qualification

11 Market Landscape

11.1 Market Overview

11.2 Market Size & Forecast

11.2.1 Insights by Indication

11.2.2 Insights by Application

11.2.3 Insights by Type

11.2.4 Insights by Geography

11.3 Five Forces Analysis

12 Indication

12.1 Market Snapshot & Growth Engine

12.2 Market Overview

12.3 Oncology

12.4 Cardiology

12.5 Neurology

12.6 Immunology

12.7 Others

13 Application

13.1 Market Snapshot & Growth Engine

13.2 Market Overview

13.3 Diagnostics

13.4 Drug Discovery & Development

13.5 Personalized Medicine

13.6 Others

14 Type

14.1 Market Snapshot & Growth Engine

14.2 Market Overview

14.3 Diagnostic Biomarkers

14.4 Monitoring Biomarkers

14.5 Prognostic Biomarkers

14.6 Predictive Biomarkers

14.7 Susceptibility Biomarkers

14.8 Other Biomarkers

15 Geography

15.1 Market Snapshot & Growth Engine

15.2 Geographic Overview

For more information about this report visit https://www.researchandmarkets.com/r/u2gu42

More:
Global Biomarkers Market Outlook & Forecast 2022-2027: Increase In Number of Pipeline Biomarkers & Rising Adoption of Biomarkers In Disease...